Clearmind Medicine Shares Drop 45% After Pricing of Direct Offering

By Chris Wack Clearmind Medicine shares were down 45% to $1.62 after the company entered into definitive agreements with institutional investors for the...

Related Keywords

Chris Wack ,Drug Administration ,Clearmind Medicine ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Healthcare Life Sciences ,Biopharmaceuticals ,Financial Performance ,Share Price Movement Disruptions ,Corporate Funding ,Ownership Changes ,Acquisitions Mergers Shareholdings ,Corporate Actions ,Corporate Industrial News ,Private Placements ,Warrants ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,C Amp Ampe Industry News Filter ,Synd ,Cmnd L ,Ca1850534027 ,Share Price Movement ,Disruptions ,Acquisitions ,Mergers ,Shareholdings ,Corporate ,Industrial News ,Healthcare ,Life Sciences ,